SEC Form 4 · accession 0000899243-18-029881
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Trojer
Officer — Chief Scientific Officer
Period of report
Nov 28, 2018
Accepted (ET)
Nov 30, 2018 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.74 | Nov 28, 2018 | A | 40,000 | A | — | Nov 27, 2028 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1This option was granted on November 28, 2018, and the shares underlying the option vest in equal quarterly installments through November 28, 2022, subject to continued service.